Poxel Raises €16 Million
Poxel SA, a French drug development spinout from Merck Serono, has raised €16 million in Series A funding. Edmond de Rothschild Investment Partners led the round, and was joined by InnoBio and Crédit Agricole Private Equity. The company's lead candidate is focused on Type 2 diabetes.
8 July 2010•6 mins read
